Acciones GSRX Industries Inc. Other OTC
Acciones
GSRX
US36255V1070
Farmacéuticos
Ventas 2018 | 2,68 2,47 | Ventas 2019 | 11 10,12 | Capitalización | 1,34 M 1,23 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -16 M -14,72 M | Resultado Neto 2019 | -36 M -33,11 M | VE / Ventas 2018 | 26.486.381 x |
Posición de caja neta 2018 | 1,31 M 1,21 M | Deuda neta 2019 | 2,27 M 2,09 M | VE / Ventas 2019 | 328.290 x |
P/E ratio 2018 |
-4,29
x | P/E ratio 2019 |
-0,03
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 13,26 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 10/03/20 |
Director of Finance/CFO | 63 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Troy Nihart
CEO | Chief Executive Officer | 46 | 10/03/20 |
Jeff Rogers
BRD | Director/Board Member | 61 | 10/03/20 |
Shaun Dale
BRD | Director/Board Member | 47 | 23/04/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+31,37 % | 588 mil M | |
-2,80 % | 364 mil M | |
+20,52 % | 326 mil M | |
+5,55 % | 285 mil M | |
+14,83 % | 239 mil M | |
+9,93 % | 210 mil M | |
-6,95 % | 200 mil M | |
+10,84 % | 167 mil M | |
+0,16 % | 161 mil M |